Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE.BARDA - ASPR / DAAPPO / BARDA DCMA
This opportunity closed August 15, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)OpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses Sep 2028
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Biocontainment Facility Operational Readiness and CommissioningOpenAGRICULTURE, DEPARTMENT OFNo deadline listed
- RFI: Specialized Domestic and International Cold-Chain Logistics Services for the International Reagent Resource (IRR)OpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Notice of Intent for Forum on Medical and Public Health Preparedness for Disasters and EmergenciesOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
About this archived opportunity
: BARDA seeks Contractor(s) to support the continuation of the Vaccine MCMs for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: Holding a U.S. influenza vaccine license; or Have developed an influenza vaccine as evidenced by: a.Submission of a BLA for seasonal or pandemic influenza vaccine Please see attachment to this presolicitation notice for further important information.
Historical details
- Status
- Closed
- Deadline
- August 15, 2026
- First captured
- July 31, 2026
- Publisher reference
- 7f2d0909120749a39c61c64ff933f1a6
Eligibility: No Set aside used
Free. One email, sent if this program reopens or a close match to it opens. We watch for 12 months, then stop. No list.
Related opportunities
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)HEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses Sep 2028
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakHEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Biocontainment Facility Operational Readiness and CommissioningAGRICULTURE, DEPARTMENT OF
- RFI: Specialized Domestic and International Cold-Chain Logistics Services for the International Reagent Resource (IRR)HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Notice of Intent for Forum on Medical and Public Health Preparedness for Disasters and EmergenciesHEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersDEPT OF DEFENSECloses Oct 2028